Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gregory

Showing results (991-1000 of 1,034) with videos related to

Pageof 104
Sort By:
Blood Cancer Journal|March 12, 2016
Lenalidomide treatment and prognostic markers in relapsed or refractory chronic lymphocytic leukemia: data from the prospective, multicenter phase-II CLL-009 trialA Bühler, C-M Wendtner, T J Kipps, et al.
Leukemia|December 17, 2015
Genetic factors influencing the risk of multiple myeloma bone diseaseD C Johnson, N Weinhold, J Mitchell, et al.
Neurology|September 19, 2008
Neurodegeneration associated with genetic defects in phospholipase A(2)A Gregory, S K Westaway, I E Holm, et al.
The EMBO Journal|July 30, 2014
Genome-wide identification of miR-200 targets reveals a regulatory network controlling cell invasionCameron P Bracken, Xiaochun Li, Josephine A Wright, et al.
Nature Communications|February 4, 2022
Tracking cryptic SARS-CoV-2 lineages detected in NYC wastewaterDavida S Smyth, Monica Trujillo, Devon A Gregory, et al.
Stem Cells Translational Medicine|September 10, 2021
A scalable system for generation of mesenchymal stem cells derived from induced pluripotent cells employing bioreactors and degradable microcarriersRobert E Rogers, Andrew Haskell, Berkley P White, et al.
JHEP Reports : Innovation in Hepatology|June 17, 2024
Metabolome-wide association identifies altered metabolites and metabolic pathways in the serum of patients with cholangiocarcinomaLinsey E Jackson, Jennifer L Tomlinson, Roberto Alva-Ruiz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 12, 2010
Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastomaTracy T Batchelor, Dan G Duda, Emmanuelle di Tomaso, et al.
Blood|September 7, 2013
Regulation of vascular leak and recovery from ischemic injury by general and VE-cadherin-restricted miRNA antagonists of miR-27Jennifer A Young, Ka Ka Ting, Jia Li, et al.
Experimental Hematology|June 1, 1997
Cell cycle kinetic studies in 68 patients with myelodysplastic syndromes following intravenous iodo- and/or bromodeoxyuridineA Raza, S Alvi, L Broady-Robinson, et al.
Pageof 104

Showing results (991-1000 of 1,034) with videos related to

Sort By:
Pageof 104
Blood Cancer Journal|March 12, 2016
Lenalidomide treatment and prognostic markers in relapsed or refractory chronic lymphocytic leukemia: data from the prospective, multicenter phase-II CLL-009 trialA Bühler, C-M Wendtner, T J Kipps, et al.
Leukemia|December 17, 2015
Genetic factors influencing the risk of multiple myeloma bone diseaseD C Johnson, N Weinhold, J Mitchell, et al.
Neurology|September 19, 2008
Neurodegeneration associated with genetic defects in phospholipase A(2)A Gregory, S K Westaway, I E Holm, et al.
The EMBO Journal|July 30, 2014
Genome-wide identification of miR-200 targets reveals a regulatory network controlling cell invasionCameron P Bracken, Xiaochun Li, Josephine A Wright, et al.
Nature Communications|February 4, 2022
Tracking cryptic SARS-CoV-2 lineages detected in NYC wastewaterDavida S Smyth, Monica Trujillo, Devon A Gregory, et al.
Stem Cells Translational Medicine|September 10, 2021
A scalable system for generation of mesenchymal stem cells derived from induced pluripotent cells employing bioreactors and degradable microcarriersRobert E Rogers, Andrew Haskell, Berkley P White, et al.
JHEP Reports : Innovation in Hepatology|June 17, 2024
Metabolome-wide association identifies altered metabolites and metabolic pathways in the serum of patients with cholangiocarcinomaLinsey E Jackson, Jennifer L Tomlinson, Roberto Alva-Ruiz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 12, 2010
Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastomaTracy T Batchelor, Dan G Duda, Emmanuelle di Tomaso, et al.
Blood|September 7, 2013
Regulation of vascular leak and recovery from ischemic injury by general and VE-cadherin-restricted miRNA antagonists of miR-27Jennifer A Young, Ka Ka Ting, Jia Li, et al.
Experimental Hematology|June 1, 1997
Cell cycle kinetic studies in 68 patients with myelodysplastic syndromes following intravenous iodo- and/or bromodeoxyuridineA Raza, S Alvi, L Broady-Robinson, et al.
Pageof 104